Weihao Li

发表

The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator

Z. Pan, Zhen-hai Lu, Jiarui He, 2022, Pathology & Oncology Research.

Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study

Z. Pan, Xiaojun Wu, Kun Wang, 2022, Frontiers in Pharmacology.

Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer

K. Han, Jian Zheng, P. Ding, 2022, Nature Communications.

Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer

Z. Pan, Xiaoping Lin, J. Peng, 2020, Frontiers in Pharmacology.

Surgery Prolongs the Survival of Patients with Metastatic, Recurrent, or Unresectable Locally Advanced Gastrointestinal Stromal Tumors Response to Imatinib Mesylate Treatment: A Systematic Review and Meta-analysis

Z. Pan, D. Wan, Xiaojun Wu, 2021 .

Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer

Z. Pan, D. Wan, Xiaojun Wu, 2021, Cancer Cell International.

Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China

Z. Pan, Zhen-hai Lu, Xiaojun Wu, 2021, Frontiers in Surgery.

Surgical and Oncological Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients from A Single Center in China

Z. Pan, Zhen-hai Lu, Xiaojun Wu, 2021 .

Prognosis and risk factors for the development of pulmonary metastases after preoperative chemoradiotherapy and radical resection in patients with locally advanced rectal cancer.

Z. Pan, Xiaojun Wu, Cong Li, 2020, Annals of translational medicine.

Cervical lymph node metastasis of bladder cancer: a case report and review of literature.

L. Nie, Ruining Zhao, Yajie Li, 2023, The aging male : the official journal of the International Society for the Study of the Aging Male.

Application of Tumor Burden Score for predicting conversion outcome in patients with initially unresectable colorectal liver metastases after first-line systemic therapy

Z. Pan, Xiaojun Wu, Hui Sun, 2021, Therapeutic advances in gastroenterology.

Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4‐mediated Ferroptosis in Colorectal Cancer

Yue Xing, K. Zeng, Yue Wang, 2023, Advanced science.

Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.

Z. Pan, Jiarui He, J. Peng, 2023, European journal of radiology.

Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer

Zhen-hai Lu, Xiaojun Wu, Yanbo Xu, 2023, Autophagy.

Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience

Z. Pan, Zhen-hai Lu, Xiaojun Wu, 2019, Cancer communications.

Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death

Z. Zeng, J. Peng, Weihao Li, 2024, Nature communications.

A positive feedback circuit driven by m6A-modified circular RNA facilitates colorectal cancer liver metastasis

J. Peng, Z. Pan, Weili Zhang, 2023, Molecular cancer.

MCT4 is an independent prognostic factor and affects immune cell infiltration in patients with colorectal liver oligometastases.

J. Peng, Binyi Xiao, Weili Zhang, 2024, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Chromosomal instability is associated with prognosis and efficacy of bevacizumab after resection of colorectal cancer liver metastasis.

J. Peng, Yujing Fang, Binyi Xiao, 2024, Annals of medicine.